2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide

C35H43N5O5S — CID 171463899

IUPAC2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide
SMILESCc1cccc(C)c1-c1cc2nc(n1)NS(=O)(=O)c1cccc(c1)C(=O)N(CC(=O)NC1CC3(CCC3)C1)[C@H](CC(C)(C)C)CO2
InChIInChI=1S/C35H43N5O5S/c1-22-9-6-10-23(2)31(22)28-16-30-38-33(37-28)39-46(43,44)27-12-7-11-24(15-27)32(42)40(26(21-45-30)19-34(3,4)5)20-29(41)36-25-17-35(18-25)13-8-14-35/h6-7,9-12,15-16,25-26H,8,13-14,17-21H2,1-5H3,(H,36,41)(H,37,38,39)/t26-/m1/s1
InChIKeyBXDWPCNMFMEYBF-AREMUKBSSA-N
MW645.83 g/mol
LogP5.65
Rot. Bonds5

About 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide

2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide (PubChem CID 171463899) has the molecular formula C35H43N5O5S and a molecular weight of 645.83 g/mol. Its IUPAC name is 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide.

Molecular Properties

Compound Name2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide
PubChem CID171463899
Molecular FormulaC35H43N5O5S
Molecular Weight645.83 g/mol
Exact Mass645.30
IUPAC Name2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide
SMILESCc1cccc(C)c1-c1cc2nc(n1)NS(=O)(=O)c1cccc(c1)C(=O)N(CC(=O)NC1CC3(CCC3)C1)[C@H](CC(C)(C)C)CO2
InChIInChI=1S/C35H43N5O5S/c1-22-9-6-10-23(2)31(22)28-16-30-38-33(37-28)39-46(43,44)27-12-7-11-24(15-27)32(42)40(26(21-45-30)19-34(3,4)5)20-29(41)36-25-17-35(18-25)13-8-14-35/h6-7,9-12,15-16,25-26H,8,13-14,17-21H2,1-5H3,(H,36,41)(H,37,38,39)/t26-/m1/s1
InChIKeyBXDWPCNMFMEYBF-AREMUKBSSA-N
XLogP5.65
TPSA130.59 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500645.83
LogP ≤ 55.65
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide?
The IUPAC name of 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide (CID 171463899) is 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide.
What is the SMILES notation for 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide?
The canonical SMILES for 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide is Cc1cccc(C)c1-c1cc2nc(n1)NS(=O)(=O)c1cccc(c1)C(=O)N(CC(=O)NC1CC3(CCC3)C1)[C@H](CC(C)(C)C)CO2.
What is the InChIKey of 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide?
The InChIKey is BXDWPCNMFMEYBF-AREMUKBSSA-N. The full InChI is InChI=1S/C35H43N5O5S/c1-22-9-6-10-23(2)31(22)28-16-30-38-33(37-28)39-46(43,44)27-12-7-11-24(15-27)32(42)40(26(21-45-30)19-34(3,4)5)20-29(41)36-25-17-35(18-25)13-8-14-35/h6-7,9-12,15-16,25-26H,8,13-14,17-21H2,1-5H3,(H,36,41)(H,37,38,39)/t26-/m1/s1.
What are the key properties of 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide?
2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide has a molecular weight of 645.83 g/mol, XLogP of 5.65, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(11R)-6-(2,6-dimethylphenyl)-11-(2,2-dimethylpropyl)-2,2,13-trioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-12-yl]-N-spiro[3.3]heptan-2-ylacetamide is sourced from PubChem (CID 171463899), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).